Straumann stock slips as investors weigh latest earnings outlook

Published on 09/16/2026 at 18:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Straumann stock trades lower on September 16, 2026, with the shares down around 0.8 percent on the SIX Swiss Exchange. Recent earnings expectations and valuation metrics frame the risk reward for Straumann stock.

Reinraum-Fertigung von Dentalimplantaten mit Ingenieuren an Präzisionsmaschinen — Straumann Holding AG (CH0012280076) betreibt moderne Reinraum-Fertigung für präzise Dentalimplantate in der Schweiz, Illustration mit AI erstellt.

Straumann Holding AG (ISIN CH0012280076) stock was quoted at around CHF 95.16 on the SIX Swiss Exchange on September 16, 2026, putting the shares roughly 0.8 percent lower in afternoon trading and underperforming the Swiss Performance Index benchmark on the day, according to finanzen.ch.

Straumann stock under pressure in SPI context

As of 16:28 local time on September 16, 2026, Straumann shares were trading at CHF 95.16 on SIX SX, down from an opening level of CHF 96.08, which marks an intraday decline of around 0.8 percent and highlights selling pressure relative to the broader Swiss Performance Index, which was reported near 19,511 points at the same moment, according to finanzen.ch.

The intraday range on September 16, 2026, stretched from a day high of CHF 96.08 at the start of the session down to an intraday low of CHF 94.14, underscoring that Straumann stock has been volatile within a relatively narrow band as traders reassess the dental implant specialist’s earnings outlook, with trading volume reaching 58,398 shares by late afternoon on SIX SX, according to finanzen.ch.

52-week range and earnings expectations frame valuation

Price wise, Straumann stock remains mid range in its current 52-week corridor, with a 52-week low of CHF 73.02 and a 52-week high of CHF 109.80 on the SWX listing, meaning the latest CHF 95.16 print sits about CHF 22.14 above the low and CHF 14.64 below the high, according to structured product data that lists Straumann Holding AG as an underlying on the SIX Structured Products exchange from finanzen.ch.

Based on recent analyst models compiled in mid September 2026, experts expect Straumann to deliver earnings per share of around CHF 3.23 for the full year 2026, which sets a forward price earnings multiple in the high twenties at the current CHF 95.16 share price, highlighting that Straumann continues to trade at a premium valuation relative to many broader-market industrial and healthcare names, according to estimates cited by finanzen.ch.

At the same time, multi asset structured products that bundle Straumann with other Swiss blue chips such as Compagnie Financiere Richemont, Geberit and Swiss Re give an additional market read on risk appetite for Straumann exposure, with one barrier reverse convertible listing Straumann among the underlyings and showing a basis price of CHF 94.48 for Straumann shares as of September 16, 2026, slightly below the spot quote on SIX SX, according to data published by finanzen.ch.

Investor take: premium valuation and earnings risk

For investors, the combination of a share price roughly 14 percent below the 52-week high but more than 30 percent above the 52-week low indicates that Straumann stock is still priced for continued growth while leaving room for volatility if earnings momentum were to disappoint relative to the expected CHF 3.23 per share in 2026, according to the latest expectations cited by finanzen.ch.

That earnings outlook and the implied valuation multiple underline that Straumann remains a classic growth story within the Swiss SPI universe, but also one where near term share performance can move quickly if analyst forecasts or margin assumptions change, especially against a backdrop of sector wide sensitivity to healthcare spending and macroeconomic trends that influence demand for dental and orthodontic treatments.

Straumann stock price and market data

As of September 16, 2026, Straumann stock last traded at CHF 95.16 on the SIX Swiss Exchange, with an intraday decline of around 0.8 percent from the CHF 96.08 opening level and with the shares sitting between the documented 52-week low of CHF 73.02 and the 52-week high of CHF 109.80 on the SWX listing.